Chemoembolization of primary and secondary liver tumors
03/2021
MUDr. Jan Zavadil1; MUDr. Tomáš Rohan1; MUDr. Matej Straka1; MUDr. Lenka Ostřížková2; MUDr. Tomáš Andrašina, Ph.D., MBA1
1 Klinika radiologie a nukleární medicíny LF MU a FN Brno
2 Interní a hematoonkologická klinika LF MU a FN Brno
SUMMARY
Transarterial chemoembolization is an integral part of the treatment of intermediate primary and secondary liver tumors. Over the decades, this method has been constantly improved both in terms of technology and the possibilities of embolizing agents used and improves the prognosis of patients who often cannot undergo other therapies. This review article introduces the readers to the basic cha- racteristics of the performance itself, indications, methods, complications, and side effects. Finally, the success of the performances themselves is presented.
Key words
chemoembolization, TACE, liver tumors, hepatocellular carcinoma, Barcelona criteria
The full article is only available to subscribers
Become a regular subscriber to our Oncological Review...